Analisis Keuangan Saham MFD - MEDICAL BioHealth (SWX) Stock

MEDICAL BioHealth
CH ˙ SWX
Gambaran Umum
Ang MEDICAL BioHealth, na nakabase sa Switzerland, ay pangunahing gumagana sa loob ng sektor ng biotechnology, na nakatuon sa mga makabagong solusyon sa pangangalagang pangkalusugan. Ang kumpanya ay kilala para sa kanyang groundbreaking na trabaho sa personalized na gamot at biopharmaceuticals, na naglalayong iangkop ang mga paggamot sa mga indibidwal na genetic profile. Kabilang sa mga pangunahing proyekto ang pagbuo ng mga naka-target na therapy para sa kanser at mga advanced na biologic na paggamot para sa mga sakit na autoimmune, paggamit ng cutting-edge gene editing at molecular technology. Sa pamamagitan ng labis na pamumuhunan sa pananaliksik at pagpapaunlad, ang MEDICAL BioHealth ay hindi lamang naglalayong isulong ang medikal na agham kundi pati na rin upang mapabuti ang mga resulta ng pasyente nang malaki. Ang mga estratehikong pakikipagsosyo ng kumpanya sa mga pandaigdigang lider ng parmasyutiko at mga institusyong pang-akademiko ay binibigyang-diin ang pangako nito sa pagsasama ng pagtuklas ng siyentipiko sa klinikal na aplikasyon, na nagtutulak dito sa unahan ng industriya ng biotech.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
Efektivitas Manajemen
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
Gross Margins
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)
Grupong Pang-industriya
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista